Minerva Neurosciences Inc Cash Flow Quality Index
Minerva Neurosciences Inc cash flow quality index. Minerva Neurosciences Inc (NERV) has a Cash Flow Quality Index of -0.19x as of September 2024. Operating cash flow of $-4.35 Million is below net income of $22.51 Million, suggesting accrual-heavy earnings not yet converted to cash. See Minerva Neurosciences Inc (NERV) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Minerva Neurosciences Inc (2020–2024)
Cash flow quality index of Minerva Neurosciences Inc from 2020 to 2024. Historical Cash Flow Quality Index for Minerva Neurosciences Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore NERV operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Minerva Neurosciences Inc Cash Flow Quality Index by Year (2020–2024)
Minerva Neurosciences Inc cash flow quality index by year from 2020 to 2024. Year-by-year earnings quality comparison for Minerva Neurosciences Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Minerva Neurosciences Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -13.59x | $-19.55 Million | $1.44 Million | ▲ +22.0% |
| 2020 | -17.43x | $-33.82 Million | $1.94 Million | — |